Olink Bioscience and Pioneer Biomed Sign Distributorship Agreement for the Chinese Market
News Mar 08, 2010
Olink Bioscience has signed a distributorship agreement with Beijing Pioneer Medical Instrument Co., Ltd for distribution of the Duolink® product line in China.
"We are proud to announce the collaboration with this highly respected company" says Peter Karlberg, Director of Sales and Marketing at Olink Bioscience and continues "this agreement represents a huge commercial opportunity for Olink Bioscience and we are confident that this will bring us valuable new business both in the academic and the biotech/pharmaceutical industry throughout the country".
"The Duolink regent kit based on PLA® technology is exactly the kind of product PioneerBiomed is looking for that meet our customers demands for new and innovative research products" says Jason Zhihuan Wang, President and CEO of PioneerBiomed.
The Duolink product line is based on Olink Bioscience proprietary in situ PLA, a proximity ligation assay technology that extends the capabilities of traditional protein techniques to include direct detection of proteins, protein interactions and modifications with unparalleled specificity and sensitivity. Target proteins are detected with single molecule resolution, allowing digital quantification and information about the exact localization of the target. Furthermore, the proteins can be studied at normal expression levels in fixed cells and tissue sections.
Molecular Mechanism That Enable Neuronal Connections to Change With Development DiscoveredNews
Researchers from King's College London have discovered a molecular mechanism that enables neuronal connections to change through experience, thus fuelling learning and memory formation.READ MORE
Thermo, SRI International Collaborate to Enhance Small Molecule ResearchNews
Thermo set to collaborate with SRI International to combine results of Orbitrap LC/MS experiments with organism-specific metabolic pathway and genome data to improve small molecule research and analysis.READ MORE
Metabolomic Analysis Reveals Underlying Cause of Weaker Bones in Diabetic MiceNews
Investigators report that hyperglycemic mice have a 24-fold higher accumulation of succinate in the metabolic pathways of their bone marrow stromal cells.READ MORE
Comments | 0 ADD COMMENT
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Introduction to Metabolomics Analysis
Mar 20 - Mar 23, 2018